Clinical Trials Directory

Trials / Sponsors / Agouron Pharmaceuticals

Agouron Pharmaceuticals

Industry · 14 registered clinical trials.

StatusTrialPhaseStarted
TerminatedSafety and Effectiveness of 3 Anti-HIV Treatments in Patients Who Have Failed Previous Treatments Containing N
HIV Infections
N/A2000-08-01
CompletedA Study of Capravirine Plus VIRACEPT Plus Two Nucleoside Reverse Transcriptase Inhibitors in HIV-Infected Pati
HIV Infections
Phase 22000-02-01
CompletedCombination Treatment Using Capravirine (AG1549), Nelfinavir, and Two Nucleoside Reverse Transcriptase Inhibit
HIV Infections
Phase 22000-01-01
UnknownTreatment With Nelfinavir or Efavirenz of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs
HIV Infections
Phase 41999-12-01
SuspendedSafety and Effectiveness of a New Anti-HIV Drug (AG1549) in Combination With Other Anti-HIV Drugs in HIV-Infec
HIV Infections
Phase 21999-11-01
SuspendedEffectiveness of a New Anti-HIV Drug (AG1549) Plus Viracept (Nelfinavir) Plus Combivir (Zidovudine/Lamivudine)
HIV Infections
Phase 21999-08-01
CompletedA Study of Viracept in AIDS Patients With Mycobacterium Avium Complex Disease (MAC)
Mycobacterium Avium-Intracellulare Infection, HIV Infections
Phase 2—
CompletedViracept Expanded Access Program
HIV Infections
N/A—
CompletedSafety and Effectiveness of Treating HIV-Positive Patients With an HIV Vaccine (Remune)
HIV Infections
Phase 2—
CompletedA Study of Viracept in HIV-Positive Women
HIV Infections
Phase 2—
CompletedA Study of Viracept in AIDS Patients With Cytomegalovirus Retinitis
Cytomegalovirus Retinitis, HIV Infections
Phase 2—
UnknownEffectiveness of Treating HIV-Positive Patients With an HIV Vaccine (Remune)
HIV Infections
Phase 3—
CompletedPhase I Study of Safety, Tolerability, and Pharmacokinetics of Viracept in HIV-1 Infected Children and Exposed
HIV Infections
Phase 1—
CompletedA Pilot, Open-Label, Phase II, Randomized Study to Determine the Effects of Viracept on the Outcome of Cutaneo
Sarcoma, Kaposi, HIV Infections
Phase 2—